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Abstract: The determination of zearalenone (ZEN) and its derivatives as biomarkers in animal tissues
or organs plays an important role in mycotoxin monitoring and can promote effective exposure
assessment. A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the
simultaneous quantification of nine ZEN-like mycotoxins, including three glucuronides in different
pig tissues (heart, liver, spleen and muscle) was developed and validated in this study. Tissue samples
were extracted using a quick, easy, cheap, effective, rugged, and safe (QuEChERS) extraction and
clean-up procedure, and analyzed by LC-MS/MS in multiple reaction monitoring (MRM) mode.
Dynamic linear ranges for each target analyte were determined with R2 between 0.916 and 0.999.
The LODs of the six ZENs were achieved in the range of 0.5–1 ng/g and the LOQs varied from
1 ng/g to 2 ng/g. The satisfying intra-day and inter-day reproducibility (both RSDr and RSDR < 20%)
indicated a good stability of this method. The recoveries of the nine target analytes were in the range
of 70–110%. The validation results showed that this LC-MS/MS method coupled with QuEChERS
sample pretreatment is effective and suitable for the simultaneous quantitation of ZEN metabolites in
pigs. It has been applied to analysis of the pig tissues in this research and can be also adapted for
samples in the mycotoxin research field.
Keywords: zearalenone; LC-MS/MS; QuEChERS; pigs
Key Contribution: A method was developed for the determination of β-ZEL-14G, α-ZEL-14G,
ZEN-14GlcA in different tissues (heart, liver, spleen, muscle) from pigs for the first time. And this
method has been successfully applied in biological samples.
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1. Introduction
Mycotoxins are toxic secondary metabolites produced by various molds or fungi which are
commonly found in feed and foodstuff. Crops, such as corn, wheat and corn are easily contaminated
by mold during growth, harvest and storage [1]. Fungal mycotoxins are produced in the growth
process and exert great toxicity to human and animals. It is considered a public concern because
they have the potential to affect the animals either individually or additively in the presence of more
than one mycotoxin. Subsequently, mycotoxins may cause harm to various organs such as spleen,
liver, heart and immune system, eventually resulting in production reduce of the animals and causing
economic losses [2].
Among all mycotoxins, Zearalenone (ZEN, Figure 1), which is a non-steroidal estrogenic mycotoxin
produced by F. culmorum and F. graminearum, has several adverse effects [3–7]. Occurrence, toxicity,
and metabolism data of ZEN was summarized by the European Food Safety Authority and in several
reviews [8–11]. Subsequently, ZEN was associated with hyperestrogenism and several physiological
alterations of the reproductive tract such as infertility and low hormone levels in several laboratory
animals (mice, rat, pig) [12]. ZEN has oestrogenic effects on livestock by binding to the oestrogen
receptors ER-α and ER-β, which can cause infertility and reduce weight or embryonic death [13].
Although their modes of action are different, pigs are more sensitive to this toxin [14]. The target organ
of ZEN is mainly the reproductive system of female animals. While at the same time, it also has certain
influence on male animals. In the condition of acute poisoning, it will have some toxic effects on the
nervous system, heart, kidney, liver and lung [15].
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Figure 1. Chemical structure of 9 mycotoxins. (a) ZEN (b) ZAN (c) α-ZEL (d) β-ZEL (e) α-ZAL (f) β-
ZAL (g) ZEN-14GlcA (h) α-ZEL-14GlcA (i) β-ZEL-14GlcA. Figure 1. Chemical structure of 9 mycotoxins. (a) ZEN (b) ZAN (c) α-ZEL (d) β-ZEL (e) α-ZAL
(f) β-ZAL (g) ZEN-14GlcA (h) α-ZEL-14GlcA (i) β-ZEL-14GlcA.
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Additionally, animal data suggest that ZEN biotransformation occurs in the liver & intestinal
tissues, and lead to generation of five metabolites, including, zearalenone (ZAN, Figure 1),
β-zearalanol (β-ZAL, Figure 1), α-zearalanol (α-ZAL, Figure 1), β-zearalenol (β-ZEL, Figure 1),
α-zearalenol (α-ZEL, Figure 1) [13,16,17]. On the other hand, several studies showed that these
metabolites are glucuronidated in the organs, preferably at the sterically unhindered 14-hydroxyl-position,
and generate conjugated forms [18,19] such as β-zearalenol-glucuronide (β-ZEL-14G, Figure 1),
α-zearalenol-glucuronide (a-ZEL-14G, Figure 1), zearalenone-14-glucuronide (ZEN-14GlcA, Figure 1)
in animals. In the recent study, ZEN-14-GlcA was the predominant glucuronide, moreover the
glucuronidation rate of ZEN in pigs is likely to be faster than in other species [18]. Several studies
have revealed that ZEN and its main metabolites have anabolic activities in farm animals, especially in
pigs [20–22]. Typical symptoms described in swine and piglets are hyperemia, swelling and reddening
of the vulva in gilts, enlargement of the mammary glands and edema of the vagina [23]. A survey
in 2001 showed that clinical symptoms of ZEN could be severed by the consequence of additive
effects exerted by both ZEN and metabolic compounds [24]. On the other hand, several evidence
demonstrated that ZEN as well as its metabolites are able to cause serious health effects in pigs,
which not only lead to fertility disorders but also disturb the ovulation cycle and reduce litter
size in swine [25]. Thus, serious impact on profit may be registered by swine producers as a
result of reproductive failure related to the presence of ZEN and its metabolites in feedstuff [26].
However, in contrast to ZEN, no maximum or regulatory limits have been set for its modified forms
as the consequence of the lack of occurrence and toxicity data. To date, there is no valid method
for determining these modified forms, especially in animal-derived food. Therefore, the European
Food Safety Authority (EFSA) recently addressed the need to set a properly validated and sensitive
analytical method for detecting the modified forms of mycotoxins in these matrices [26].
Since contamination by fungal toxin frequently occur in food, regulatory limits for ZEN have
been established in many countries. Maximum permitted levels for ZEN in different foodstuffs,
introduced by EU are 350 µg/kg in unprocessed corn. The EFSA Panel on Contaminants in the
Food Chain (CONTAM) set for a no-observed-effect-level (NOEL) of 10 µg/kg bw/day for pigs and
published a tolerable daily intake (TDI) for humans of 0.25 µg/kg bw/day.
In recent years, the QuEChERS (quick, easy, cheap, effective, rugged, and safe) method is a
widely used sample preparation methodology. The method involves extraction with acetonitrile and
partitioning cleanup after the addition of a salt mixture (MgSO4 and NaCl). Clean-up is also performed
by solid-phase extraction through the addition of appropriate sorbents. As a result, this method
overcome obstacles such as high-cost, requiring skilled operation technique, low detection levels as well
as time-consuming. Therefore, it has been applied in analytical fields from drugs to mycotoxins [27–29].
Based on its toxic action as well as the economic problem caused by contaminated feedstuff,
both ZEN and its reduced metabolites should be monitored. In order to ensure people’s safety, it is
necessary to establish effective methods to detect toxins. During the past few years, a various number of
analytical methods such as enzyme-linked immunosorbent assay (ELISA), thin layer chromatography
(TLC), high-performance liquid chromatography (HPLC) and gas chromatography-tandem mass
spectrometry (GC-MS/MS) have been developed for the identification and quantification of ZEN
and other mycotoxins [30–36]. The HPLC-application is limited due to unsatisfactory accuracy
of quantification and poor separation, therefore LC/MS replaced HPLC and became the most
commonly used method for ZEN analysis [37–39]. For example, Recently, Breidbach (2017) developed
a greener, more quick approach for the determination of multiple mycotoxins including ZEN using
LC-MS/MS [40].
Pigs, especially weaning piglets, are a good model to investigate the toxic effects of ZEN and its
metabolites because of (1) the high percentage of cereals in their diet and (2) they are highly sensitive
to these compounds [26,41]. Also, ZEN-contaminated diets induced significant changes on the global
transcriptome in pig spleen, liver and other organs. Several evidences have demonstrated that the
assessment of animal exposure to ZEN and its modified compounds might not only analyze toxin
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residues in feedstuff, but also analyze the biological samples such as urine, blood, bile, spleen and liver
because in most cases, the feedstuffs cannot clearly be related to the disease risk of the animals [8,38,42].
Therefore, determination of ZEN and its derivates in different tissues can serve as biomarkers and
could promote effective exposure assessment which is significant for the establishment of regulatory
limits. Biomarker research in ZEN and its metabolites started from the 1990s. However, methods for
the simultaneous determination of ZEN and its main modified forms in biological samples are scarce
with the exception of blood for their availability and convenience [30,43]. No experiments are
available describing the bioavailability from contaminated biological samples which presumably
contain modified ZEN, especially the glycosidic bound ZEN forms (ZEN-14GlcA). The call for the
diagnosis of ZEN-like mycotoxins exposure of farm animals especially pigs becomes louder.
The prerequisite to investigate the metabolism and kinetics of ZEN family mycotoxins is the
development of analytical methods for the determination of the toxins in biological matrices such as
liver, spleen, urine and muscle. In this paper, our aim is to develop and validate an LC-MS/MS-based
QuEChERS method for the simultaneous quantification of ZEN family mycotoxins including ZEN
and most relevant key metabolites in different tissues or organs (heart, liver, spleen and muscle) from
pigs. It is the first time that a method is developed for the determination of β-ZEL-14G, α-ZEL-14G,
ZEN-14GlcA in organs from pigs. This method has been successfully applied in biological samples
contaminated by ZEN family. The determination of the nine mycotoxins in four different tissues were
revealed through this method. Thus, for the first time, a quick, easy, cheap and effective LC-MS/MS
method for the simultaneous determination of both ZEN and its key metabolites in four different type
of tissue from pigs was successfully developed.
2. Results and Discussion
2.1. Selectivity
The selectivity of the method was investigated to evaluate matrix interferences at the retention
time in blank samples. The retention time of six target mycotoxins including ZEN, ZAN, β-ZAL,
α-ZAL, β-ZEL, α-ZEL are pointed out by chromatograms of a standard mixture in Figure 2,
while the ZEN-14GlcA, β-ZEL14GlcA, α-ZEL14GlcA are showed in Figure 3. The retention time
in the chromatograms of the blank samples show high levels of reproducibility without interfering peaks,
indicating the good selectivity of the method.
2.2. Matrix Effect
Due to the complexity of biological samples, the matrix often has significant interferences on
the electrospray ionization (ESI) process, which affects the accuracy of mass spectrometric analyses.
These effects and disturbances are termed as matrix effects. Therefore, it is necessary to evaluate the
matrix effects of different tissues in mycotoxin detection; signal suppression and enhancement (SSE)
was calculated, as follows
SSE = A/C × 100 (1)
With A = the slope of the calibration curve in matrix, C = the slope of the calibration curve in neat
solvent. Generally, SSE is considered tolerable when it varies from 80 to 120%. As shown in Table 1,
SSE in liver and muscle was between 80% and 120% indicating that there is no obvious matrix effect.
However, significant signal suppression was observed for heat and spleen samples, giving SSE below
the lower limit criterion (80%). No signal enhancement was shown in all tissues samples. In order
to minimize the matrix effect and to ensure the precision of results, it is essential to establish the
matrix-matched calibration curves.
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Table 1. Linearity, correlation coefficients and SSE of six mycotoxins in different matrices from pigs.
Matrices Mycotoxins Linear Range (ng/mL) Slope Correlation Coefficient (R2) SSE (%)
Heart ZEN 2–1000 23,442 0.938 59
ZAN 2–1000 26,990 0.916 71
β-ZAL 2–1000 40,729 0.998 88
α-ZAL 2–1000 46,669 0.997 77
β-ZEL 2–1000 13,126 0.952 75
α-ZEL 2–1000 18,008 0.947 56
Liver ZEN 2–1000 39,596 0.964 100
ZAN 2–1000 44,744 0.999 118
β-ZAL 2–1000 54,313 0.998 111
α-ZAL 2–1000 66,595 0.995 110
β-ZEL 2–1000 14,801 0.999 85
α-ZEL 2–1000 25,781 0.999 80
Spleen ZEN 2–1000 17,170 0.988 43
ZAN 2–1000 23,789 0.983 63
β-ZAL 2–1000 32,231 0.979 66
α-ZAL 2–1000 39,013 0.981 65
β-ZEL 2–1000 12,221 0.999 70
α-ZEL 2–1000 18,340 0.973 57
Muscle ZEN 2–1000 34,379 0.964 88
ZAN 2–1000 40,070 0.956 106
β-ZAL 2–1000 49,359 0.999 101
α-ZAL 2–1000 65,613 0.968 108
β-ZEL 2–1000 18,425 0.999 106
α-ZEL 2–1000 28,078 0.972 88
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Figure 3. LC-MS/MS chromatograms of ZEN-14GlcA, α-ZEL-14GlcA and β-ZEL-14GlcA at 20 ng/mL.
2.3. Linearity and Sensitivity of Method
The linear regression equation is analyzed by using the peak areas obtained from each analyte
and the s qu nces of concentration. The result sh t at there is a nice linear relationship between
0.916 and 0.999 within their linea ranges. An over f linearity, correlation coefficients of six
mycotoxi s in different tissues from pigs are s in Table 1.
The sensitivity of this method was assessed by measuring limits of detection (LOD) and limits of
quantification (LOQ) in this study. The difference between the two is that the minimum concentration
specified in the LOQs should meet the requirements of precision. As shown in Table 2, the obtained
LODs and LOQs of the ZEN mycotoxins were in the range of 0.5 to 1 ng/g and 1 to 2 ng/g in the heart,
liver, spleen and muscle of pigs. The results in our study were similar to the results that the LOD of
ZEN and its metabolites varied between 0.1 ng/g and 3 ng/g for tissue samples HPLC-MS/MS [44].
Table 2. Limits of detection and quantification of six mycotoxins in four tissues from pigs. (Unit: ng/g).
Toxins
Heart Liver Spleen Muscle
LOQ LOD LOQ LOD LOQ LOD LOQ LOD
ZEN 2 1 2 1 2 1 2 1
ZAN 1 0.5 1 0.5 1 0.5 1 0.5
β-ZAL 1 0.5 1 0.5 1 0.5 1 0.5
a-ZAL 1 0.5 1 0.5 1 0.5 1 0.5
β-ZEL 1 0.5 1 0.5 1 0.5 1 0.5
a-ZEL 1 0.5 1 0.5 1 0.5 1 0.5
2.4. Intra-Day and Inter-Day Precision
The intra- and inter-day precision (%RSD) were evaluated using standard addition. Here, we use
the RSDr to represent intra-day precision and RSDR to represent inter-day precision. In this experiment,
low (5 ng/mL), intermediate (10 ng/mL) and high (20 ng/mL) concentration levels were selected
and analyzed. The precision data showed that the RSDr values in different tissues were less than
15%. The RSDR values in different tissues were higher than RSDr but were still no more than 20%,
which demonstrated the stability of this method [45]. These results are summarized in Table 3.
2.5. Extraction Recovery
For the evaluation of the recovery, standard addition method was employed in this study.
Non-contaminated matrix samples (heart, liver, spleen and muscle) were spiked with nine mycotoxins
(ZAN, ZEN, β-ZAL, α-ZAL, β-ZEL, α-ZEL, ZEN-14GlcA, β-ZEL-14GlcA, α-ZEL-14GlcA) at low
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(5 ng/mL), intermediate (10 ng/mL) and high (20 ng/mL) concentration levels, and pretreated using
the method present in Section 4.3. After analysis, the method extraction recovery (RE) was calculated as:
RE = B/D × 100 (2)
B = the slope of sample spiked after extraction, D = the slope of sample spiked before extraction.
The extration recoveries of all the spiked tissues of the nine target toxins were between 70% and 110%,
suggesting that the pretreatment method met the requirement of mycotoxin determination in the
different pig tissues [45]. These results are pointed out in Figure 4.
Table 3. Intra-day and inter-day precision in different tissues (n = 3).
Toxins
Heart Liver Spleen Muscle
RSDr RSDR RSDr RSDR RSDr RSDR RSDr RSDR
ZEN 10.4 11.9 11.3 16.4 11.1 15.1 10.8 11.7
ZAN 7.5 3.8 5.8 10.2 8.3 8.5 0.9 5.5
β-ZAL 9.1 9.4 5.6 9.1 6.2 14.3 6.0 6.5
a-ZAL 8.3 10.5 10.4 15.3 6.8 17.2 8.4 11.4
β-ZEL 5.8 8.2 8.3 18.4 4.6 7.2 8.2 8.6
a-ZEL 9.0 11.1 11.2 18.2 7.5 10.4 11.2 12.2
ZEN-14GlcA 4.6 6.2 8.1 11.9 11.5 14.7 7.1 9.0
β-ZEL-14GlcA 11.1 14.3 11.9 12.2 11.4 14.2 14.1 15.3
α-ZEL-14GlcA 6.9 9.0 6.4 9.3 8.2 15.1 8.6 9.2
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2.6. Analysis of Real Samples
The established QuEChERS pretreatment and LC-MS/MS method was applied and validated for
the analysis of 16 pig tissue samples, including 4 live samples, 4 heart samples, 4 spleen samples and
4 muscle samples muscle (ntotal = 16). The results are given in Table 4, showing that the method had
been successfully applied. In the heart sample, ZEN, ZAN and α-ZAL were not detected while the level
of two modified mycotoxins were significantly higher. Similarly, in the spleen sample, it was observed
that there were abundant more modified mycotoxins including α-ZEL-14GlcA, β-ZEL-14GlcA and
ZEN-14GlcA.However, ZEN, α-ZAL and β-ZAL were barely detected. These results might provide
a potential to find a reliable biomarker of exposure. In addition, in the liver sample, only ZAN,
ZEN-14GlcA and β-ZEL-14GlcA were detected. While ZEN, β-ZEL, α-ZEL, β-ZAL, α-ZAL and
α-ZEL-14GlcA were not detected. There was only a small amount of ZAN in the muscle samples.
The result of all mycotoxins proved the validity of our method in this study.
Table 4. Mycotoxins detected in the pig samples. ND = not detected (<LOD). (Unit: ng/g).
Mycotoxins Sample1 A Sample2 A Sample3 A Sample4 A
ZEN ND ND ND ND
β-ZEL ND 9.49 8.43 1.88
α-ZEL 2.27 1.68 2.12 <LOQ
ZAN ND ND ND 6.02
β-ZAL 0.87 ND ND ND
α-ZAL ND ND ND ND
ZEN-14GlcA <LOQ 9.07 22.91 18.32
β-ZEL-14GlcA 1.21 2.36 5.06 5.31
α-ZEL-14GlcA 4.35 ND ND ND
A ZEN-like mycotoxins detected in heart sample from pigs.
Mycotoxins Sample1 B Sample2 B Sample3 B Sample4 B
ZEN <LOQ ND ND ND
β-ZEL 2.40 ND 11.04 12.81
α-ZEL 2.09 6.73 ND ND
ZAN 11.54 11.77 4.58 <LOQ
β-ZAL <LOQ ND ND ND
α-ZAL ND ND ND ND
ZEN-14GlcA 47.81 18.68 6.46 14.99
β-ZEL-14GlcA 40.92 28.13 1.49 1.30
α-ZEL-14GlcA 17.80 5.34 ND ND
B ZEN-like mycotoxins detected in spleen sample from pigs.
Mycotoxins Sample1 C Sample2 C Sample3 C Sample4 C
ZEN ND ND ND ND
β-ZEL ND ND ND ND
α-ZEL 1.55 ND ND ND
ZAN 4.26 4.94 4.66 4.12
β-ZAL ND ND ND ND
α-ZAL ND ND ND ND
ZEN-14GlcA 1.60 6.09 17.77 11.37
β-ZEL-14GlcA <LOQ 1.12 4.20 3.27
α-ZEL-14GlcA ND ND ND ND
C ZEN-like mycotoxins detected in liver sample from pigs.
Mycotoxins Sample1 D Sample2 D Sample3 D Sample4 D
ZEN ND ND ND ND
β-ZEL ND ND ND ND
α-ZEL ND ND ND <LOQ
ZAN 3.85 5.56 4.33 5.12
β-ZAL ND ND ND ND
α-ZAL ND ND ND ND
ZEN-14GlcA <LOQ ND ND ND
β-ZEL-14GlcA ND ND ND ND
α-ZEL-14GlcA ND ND ND ND
D ZEN-like mycotoxins detected in muscle sample from pigs.
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3. Conclusions
At present, there are many researches on ZEN in food and feed crops, plants and herbs. However,
till now only few studies have been executed on animals. The challenge for exposure assessment
is that not only the parent toxin has to be detected, but also the metabolites should be considered,
especially ZEN-14GlcA, β-ZEL-14GlcA and α-ZEL-14GlcA. Quantitation of ZEN-like mycotoxins
including its key metabolites in biological samples does not enable evaluation of ZEN exposure
in pig, but also allows the risk assessment for human health. In this study, we have successfully
validated and applied an LC-MS/MS based method coupled with a QuEChERS pretreatment for
the simultaneous quantification of ZEN-like mycotoxins including ZEN and its most relevant key
metabolites in tissues from different organs (heart, liver, spleen and muscle) in pigs. We detected the
modified forms of ZEN including ZEN-14GlcA, β-ZEL-14GlcA, α-ZEL-14GlcA in different animal
tissues for the first time. The results showed that there is a linear relationship between 0.916 and
0.999 within their linear ranges. The recoveries of all the spiked tissues of the nine target toxins were
between 70% and 110%, suggesting that the pretreatment method met the requirement of mycotoxin
determination in the different pig tissues. This method has been successfully applied in real samples
contaminated by ZEN-like mycotoxins. In our study, ZEN family especially modified mycotoxins were
clearly detected in the pig tissues except muscle sample. The results showed that ZEN was absent
or in low concentration, and ZAN was detected in all tissues except heart. The results noted in pig’s
tissues exposed to low doses of ZEN were consistent with research findings in female wild boars [11].
The amounts of ZEN-14GlcA and β-ZEL-14GlcA were high in heart, liver and spleen. Since ZEN
glucuronides were not found in crops, so the results indicate that ZEN glucuronides are pig metabolites
transformed from ZEN. On the one hand, localization of each mycotoxin in different studied tissues
may provide the information to study metabolism and discover biomarkers of ZEN mycotoxins in pig.
On the other hand, this quick, easy and effective assay will contribute to ZEN-biomarker determination
and will promote its exposure assessment.
4. Materials and Methods
4.1. Chemical and Apparatus
The solid standards of ZEN, ZAN, β-ZAL, α-ZAL, β-ZEL, α-ZEL and C13-ZEN were obtained
from Sigma (St. Louis, MO, USA) and stored at −20 ◦C before use. The standards of ZEN-14GlcA,
β-ZEL-14GlcA, α-ZEL-14GlcA were provided by the lab of Dr. Bart Huyberchts at CODA-CERVA.
All organic solvents, salts and acid were analytical or HPLC grade. Acetonitrile, methanol, hexane,
and isopropanol were purchased from Honeywell. Ammonium acetate and formic acid were purchased
from Sigma. Milli-Q-quality water (Millipore, Billerica, MA, USA) was used throughout the experiments.
C18-columns were obtained from Agela Technologies (Tianjin, China).
4.2. Preparation of Standard Solutions
The standards of ZAN, β-ZAL, α-ZAL were accurately weighed, and dissolved in pure acetonitrile
to stock solutions at 10 µg/mL. The standards of ZEN, β-ZEL, α-ZEL were prepared in acetonitrile at
a concentration of 1, 2, 5, 10, 20, 50, 100 ng/mL. The solution of C13-ZEN (100 ng/mL) was prepared.
All standard solutions were freshly prepared.
4.3. Sample Pretreatment
The heart (n = 4), liver (n = 4), spleen (n = 4), muscle (n = 4) samples from pigs were provided by
the Academy of State Administration of Grain P.R.C. The blank samples (heart, spleen, liver, muscle)
were obtained from local supermarket in Shanghai and verified with ZENs not detectable. All samples
were cut into the slice around 10 g, and then stored at −80 ◦C before pretreatment. Sample preparation
protocols based on the QuEChERS method were used in the study. Each tissue was homogenized for
120 s on an automatic fast sample grinding instrument. The homogenized sample of 1 g was accurately
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weighed, mixed with 5 mL water and 5 mL of acetonitrile (formic acid 0.1%) and shaken for 2 min.
It was then placed into an ultrasonic extractor for 30 min. Thereafter 2 g of MgSO4 and 0.5 g of NaCl
were subsequently added, followed by shaking for 2 min. The samples were centrifuged for 5 min at
4000 rpm at room temperature. The supernatant of 1 mL was mixed with 50 mg of C18 and 100 mg of
MgSO4, shaken for 2 min, and centrifuged at 4000 rpm for 5 min. Then, the supernatant was collected
and dried under a gentle stream of nitrogen gas at 50 ◦C. The residue was dissolved in 400 µL of
acetonitrile/water (50:50, v/v), and mixed by 400 µL of hexane. After centrifugation at 5000 rpm for
5 min, the aqueous phase was collected, and passed through the 0.22 µm nylon filter for analysis.
4.4. LC-MS/MS Analysis
The LC-MS/MS system (TSQ Vantage) was utilized for the simultaneous determination of
mycotoxins. The chromatographic column used in this method was an Agilent Extend-C18 (100 mm ×
4.6 mm, 3.5 µm) column with a flow rate of 0.35 mL/min at 30 ◦C. The sample injection volume was
10 µL. The mobile phase was composed of phase A (5 mM ammonium acetate) and phase B (methanol).
The elution program was set as follows: 5%B (initial), 5–15%B (0–2 min), 15–50%B (2–5 min), 50–100%B
(5–20 min), 100%B (20–22 min), 100–5%B (22–22.1 min), and held a further 4 min for re-equilibration.
The flow rate was 350 µL/min and the total run time was 25 min. Mass spectrometry analysis was
carried out in both positive and negative ionization mode using multiple reaction monitoring (MRM).
The optimized conditions were used for analysis: the vaporizer temperature 300 ◦C; the ion transfer
tube temperature 350 ◦C spray voltage of negative ESI 3 KV; sheath gas pressure 30 psi; aux flow
15 arb; collision gas (argon) pressure 1.5 mTorr. Table 5 summarizes the optimized MS/MS parameters
of the nine mycotoxins in MRM mode.
Table 5. MS/MS parameters of nine mycotoxins in MRM mode.
Toxins Precursor Ion (m/z) Product Ions (m/z) Collision Energy (eV) Retention Time (min) Ratio 2 (%)
ZEN 317.0
175.0 1 25.0
15.4 70.5131.0 31.0
β-ZEL 319.2
275.2 1 21.0
13.3 11.9160.3 33.0
α-ZEL 319.2
275.2 1 21.0
14.6 11.1160.3 33.0
ZAN 319.2
275.2 1 23.0
14.9 93.1205.2 24.0
β-ZAL 321.1
277.2 1 23.0
12.7 29.3303.2 22.0
α-ZAL 321.1
277.2 1 23.0
14.3 28.8303.2 22.0
ZEN-14GlcA 493.1
317.0 1 31.0
8.8 40.3175.0 21.0
β-ZEL-14GlcA 495.1
319.0 1 22.0
7.4 40.5113.0 28.0
α-ZEL-14GlcA 495.1
319.0 1 22.0
8.5 35.0113.0 28.0
C13 335.0
185.0 1 27.0
15.2 93.3140.0 34.0
1 Quantifying ion; 2 defined as the peak area of qualifier in percent of quantifier.
4.5. Method Validation
Matrix effect, linearity, limit of detection (LOD), limit of quantification (LOQ), intra- and inter-day
precision and extraction recovery were evaluated blank tissues (heart, spleen, liver as well as muscle)
were used for all spiking experiments to validate the method in this study.
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4.5.1. Matrix Effect
The matrix effect was measured by calculating the ratio of the slope of the spiked extract (A) and
pure standard (C). The analysis value of the standard solution was considered as 100%. The signal
suppression and enhancement were used to estimate the matrix effect.
4.5.2. Calibration and Linearity
The linearity was evaluated using matrix-matched calibration curves by spiking blank tissues
at 3 concentrations. Calibration curves were constructed by concentration sequences of each analyte.
The concentration ranges for all of the analytes were as follows: ZEN, ZAN, β-ZAL, α-ZAL, β-ZEL,
α-ZEL at 1–1000 ng/g; ZEN-14GlcA, β-ZEL-14GlcA, α-ZEL-14GlcA at 1–100 ng/g. The coefficient of
determination (R2) was calculated by means of the least-square approach.
4.5.3. Limits of Detection (LOD) and Limits of Quantification (LOQ)
The LOD refers to the lowest concentration component or the minimum quantity that can be
detected through the analysis method under defined experimental conditions. The LOQ refers to the
lowest concentration component or the minimum quantity of samples to be measured that can be
detected through the analysis method. In our study, by determining with serial dilution, the LOD is
the minimum concentration giving a detectable signal [qualifying ion S\N~3], whereas the LOQ is the
minimum concentration giving a solid peak for quantitation [quantifying ion S\N~10].
4.5.4. Intra-Day and Inter-Day Precision
With respect to intra- and inter-day precision of the method, Low, intermediate and high
concentration levels of mycotoxins (5, 10, 20 ng/mL for ZEN, ZAN, β-ZAL, α-ZAL, β-ZEL, α-ZEL,
β-ZEL-14GlcA, α-ZEL-14GlcA, ZEN-14GlcA) were spiked into the blank samples (n = 3), followed by
pretreatment as described in Section 4.3. The intra-day and inter-day reproducibility was calculated
as relative standard deviation (RSDr and RSDR) by analyzing the samples in triplet every day and in
continuous three days.
4.5.5. Recovery
The recovery was assessed by comparing the peak area of blank samples where nine mycotoxins
had been added before and after the extraction process at three different concentrations (5 ng/mL,
10 ng/mL, 20 ng/mL). The ratio can be subject to evaluate the recovery of the method.
Acknowledgments: The authors highly appreciate the financial supports from The National Key Research and
Development Program of China (SQ2017YFC160102-04), National Natural Science Foundation of China (31772087,
31471661, 31601575, 31701721 and 31201378) and MOST (201513006, 2016YFE0112900).
Author Contributions: C.S. and A.W. conceived and designed the experiments; Z.Y. and L.W. performed the
experiments and analyzed the data; J.W., Y.T., D.Z., X.C., D.Y., Y.F., D.Y., C.W. contributed reagents/materials/analysis
tools; L.W., Z.Y. and A.W. wrote the manuscript, and M.D.B., S.D.S., Y.T. and A.W. revised the paper.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Bennett, J.W.; Klich, M. Mycotoxins. Clin. Microbiol. Rev. 2003, 16, 497–516. [CrossRef] [PubMed]
2. Murugesan, G.R.; Ledoux, D.R.; Naehrer, K.; Berthiller, F.; Applegate, T.J.; Grenier, B.; Phillips, T.D.;
Schatzmayr, G. Prevalence and effects of mycotoxins on poultry health and performance, and recent
development in mycotoxin counteracting strategies1. Poult. Sci. 2015, 94, 1298–1315. [CrossRef] [PubMed]
3. Antonissen, G.; An, M.; Pasmans, F.; Ducatelle, R.; Verbrugghe, E.; Vandenbroucke, V.; Li, S.; Haesebrouck, F.;
Immerseel, F.V.; Croubels, S. The Impact of Fusarium Mycotoxins on Human and Animal Host Susceptibility
to Infectious Diseases. Toxins 2014, 6, 430–452. [CrossRef] [PubMed]
Toxins 2018, 10, 129 12 of 14
4. Marroquíncardona, A.G.; Johnson, N.M.; Phillips, T.D.; Hayes, A.W. Mycotoxins in a changing global
environment—A review. Food Chem. Toxicol. 2014, 69, 220–230. [CrossRef] [PubMed]
5. Hussein, H.S.; Brasel, J.M. Toxicity, metabolism, and impact of mycotoxins on humans and animals. Toxicology
2001, 167, 101–134. [CrossRef]
6. D’Mello, J.P.F.; Placinta, C.M.; Macdonald, A.M.C. Fusarium mycotoxins: A review of global implications for
animal health, welfare and productivity. Anim. Feed Sci. Technol. 1999, 80, 183–205. [CrossRef]
7. Zinedine, A.; Soriano, J.M.; Molto, J.C.; Manes, J. Review on the toxicity, occurrence, metabolism, detoxification,
regulations and intake of zearalenone: An oestrogenic mycotoxin. Food Chem. Toxicol. 2007, 45, 1–18. [CrossRef]
[PubMed]
8. Gromadzka, K.; Waskiewicz, A.; Chelkowski, J.; Golinski, P. Zearalenone and its metabolites: Occurrence,
detection, toxicity and guidelines. World Mycotoxin J. 2008, 1, 209–220. [CrossRef]
9. Marin, D.E.; Motiu, M.; Taranu, I. Food contaminant zearalenone and its metabolites affect cytokine synthesis
and intestinal epithelial integrity of porcine cells. Toxins 2015, 7, 1979–1988. [CrossRef] [PubMed]
10. Belhassen, H.; Arrebola, J.P.; Ghali, R.; Ghorbel, H.; Olea, N.; Hedili, A. Zearalenone and its metabolites
in urine and breast cancer risk: A case-control study in Tunisia. Chemosphere 2015, 128, 1–6. [CrossRef]
[PubMed]
11. Gaje˛cka, M.; Sławuta, P.; Nicpon´, J.; Kołacz, R.; Kiełbowicz, Z.; Zielonka, Ł.; Da˛browski, M.; Szweda, W.;
Gaje˛cki, M.; Nicpon´, J. Zearalenone and its metabolites in the tissues of female wild boars exposed per os to
mycotoxins. Toxicon 2016, 114, 1–12. [CrossRef] [PubMed]
12. Haschek, W.M.; Haliburton, J.C. Fusarium Moniliforme and Zearalenone Toxicoses in Domestic Animals: A Review;
Springer: Dordrecht, The Netherlands, 1986; pp. 213–235.
13. Metzler, M.; Pfeiffer, E.; Hildebrand, A.A.; Shephard, G.S. Zearalenone and its metabolites as endocrine
disrupting chemicals. World Mycotoxin J. 2010, 3, 385–401. [CrossRef]
14. Döll, S.; Dänicke, S. The Fusarium toxins deoxynivalenol (DON) and zearalenone (ZON) in animal feeding.
Prev. Vet. Med. 2011, 102, 132. [CrossRef] [PubMed]
15. Conková, E.; Laciaková, A.; Pástorová, B.; Seidel, H.; Kovác, G. The effect of zearalenone on some enzymatic
parameters in rabbits. Toxicol. Lett. 2001, 121, 145–149. [CrossRef]
16. Belhassen, H.; JiménezDíaz, I.; Ghali, R.; Ghorbel, H.; MolinaMolina, J.M.; Olea, N.; Hedili, A. Validation of
a UHPLC-MS/MS method for quantification of zearalenone, α-zearalenol, β-zearalenol, α-zearalanol,
β-zearalanol and zearalanone in human urine. J. Chromatogr. B 2014, 962, 68–74. [CrossRef] [PubMed]
17. Metzler, M. Proposal for a uniform designation of zearalenone and its metabolites. Mycotoxin Res. 2011, 27,
1–3. [CrossRef] [PubMed]
18. Pfeiffer, E.; Hildebrand, A.; Mikula, H.; Metzler, M. Glucuronidation of zearalenone, zeranol and four metabolites
in vitro: Formation of glucuronides by various microsomes and human UDP-glucuronosyltransferase isoforms.
Mol. Nutr. Food Res. 2010, 54, 1468–1476. [CrossRef] [PubMed]
19. Binder, S.B.; Schwartz-Zimmermann, H.E.; Varga, E.; Bichl, G.; Michlmayr, H.; Adam, G.; Berthiller, F.
Metabolism of Zearalenone and Its Major Modified Forms in Pigs. Toxins 2017, 9, 56. [CrossRef] [PubMed]
20. Frizzell, C.; Ndossi, D.; Verhaegen, S.; Dahl, E.; Eriksen, G.; Sørlie, M.; Ropstad, E.; Muller, M.; Elliott, C.T.;
Connolly, L. Endocrine disrupting effects of zearalenone, alpha- and beta-zearalenol at the level of nuclear
receptor binding and steroidogenesis. Toxicol. Lett. 2011, 206, 210–217. [CrossRef] [PubMed]
21. Thomas, M.P.; Potter, B.V.L. The structural biology of oestrogen metabolism. J. Steroid Biochem. Mol. Biol.
2013, 137, 27–49. [CrossRef] [PubMed]
22. Rychlik, M.; Humpf, H.U.; Marko, D.; Dänicke, S.; Mally, A.; Berthiller, F.; Klaffke, H.; Lorenz, N. Proposal of
a comprehensive definition of modified and other forms of mycotoxins including “masked” mycotoxins.
Mycotoxin Res. 2014, 30, 197–205. [CrossRef] [PubMed]
23. Dacasto, M.; Rolando, P.; Nachtmann, C.; Ceppa, L.; Nebbia, C. Zearalenone mycotoxicosis in piglets suckling
sows fed contaminated grain. Vet. Hum. Toxicol. 1995, 37, 359–361. [PubMed]
24. Minervini, F.; Dell’Aquila, M.E.; Maritato, F.; Minoia, P.; Visconti, A. Toxic effects of the mycotoxin zearalenone
and its derivatives on in vitro maturation of bovine oocytes and 17 beta-estradiol levels in mural granulosa cell
cultures. Toxicol. In Vitro 2001, 15, 489–495. [CrossRef]
Toxins 2018, 10, 129 13 of 14
25. Osweiler, G.D.; Carson, T.L.; Buck, W.B.; Gelder, G.A.V. Clinical and Diagnostic Veterinary Toxicology;
Kendall Hunt Pub. Co.: Dubuque, IA, USA, 1985.
26. Ramos-Peralonso, M.J. European Food Safety Authority (EFSA). Encyoloped Toxicol. 2014, 554–556.
27. Azaiez, I.; Giusti, F.; Sagratini, G.; Mañes, J.; Fernández-Franzón, M. Multi-mycotoxins Analysis in Dried
Fruit by LC/MS/MS and a Modified QuEChERS Procedure. Food Anal. Methods 2014, 7, 935–945. [CrossRef]
28. Dzuman, Z.; Zachariasova, M.; Lacina, O.; Veprikova, Z.; Slavikova, P.; Hajslova, J. A rugged high-throughput
analytical approach for the determination and quantification of multiple mycotoxins in complex feed matrices.
Talanta 2014, 121, 263–272. [CrossRef] [PubMed]
29. Núñez, O.; Gallartayala, H.; Martins, C.P.; Lucci, P. New trends in fast liquid chromatography for food and
environmental analysis. J. Chromatogr. A 2012, 1228, 298–323. [CrossRef] [PubMed]
30. Gutzwiller, A.; Gafner, J.L.; Silacci, P. Urinary zearalenone measured with ELISA as a biomarker of zearalenone
exposure in pigs. Mycotoxin Res. 2014, 30, 187–190. [CrossRef] [PubMed]
31. Takagi, M.; Uno, S.; Kokushi, E.; Shiga, S.; Mukai, S.; Kuriyagawa, T.; Takagaki, K.; Hasunuma, H.; Matsumoto, D.;
Okamoto, K.; et al. Measurement of urinary zearalenone concentrations for monitoring natural feed contamination
in cattle herds: On-farm trials. J. Anim. Sci. 2011, 89, 287–296. [CrossRef] [PubMed]
32. Liu, N.; Nie, D.; Zhao, Z.; Meng, X.; Wu, A. Ultrasensitive immunoassays based on biotin–streptavidin
amplified system for quantitative determination of family zearalenones. Food Control 2015, 57, 202–209.
[CrossRef]
33. Tamura, M.; Mochizuki, N.; Nagatomi, Y.; Harayama, K.; Toriba, A.; Hayakawa, K. A Method for Simultaneous
Determination of 20 Fusarium Toxins in Cereals by High-Resolution Liquid Chromatography-Orbitrap Mass
Spectrometry with a Pentafluorophenyl Column. Toxins 2015, 7, 1664–1682. [CrossRef] [PubMed]
34. Rodríguezcarrasco, Y.; Moltó, J.C.; Mañes, J.; Berrada, H. Development of a GC-MS/MS strategy to determine
15 mycotoxins and metabolites in human urine. Talanta 2014, 128, 125–131. [CrossRef] [PubMed]
35. Rodríguez-Carrasco, Y.; Moltó, J.C.; Mañes, J.; Berrada, H. Exposure assessment approach through
mycotoxin/creatinine ratio evaluation in urine by GC-MS/MS. Food Chem. Toxicol. 2014, 72, 69–75. [CrossRef]
[PubMed]
36. Rodríguez-Carrasco, Y.; Moltó, J.C.; Berrada, H.; Mañes, J. A survey of trichothecenes, zearalenone and
patulin in milled grain-based products using GC-MS/MS. Food Chem. 2014, 146, 212–219. [CrossRef]
[PubMed]
37. Veršilovskis, A.; Huybrecht, B.; Tangni, E.K.; Pussemier, L.; De Saeger, S.; Callebaut, A. Cross-reactivity of
some commercially available deoxynivalenol (DON) and zearalenone (ZEN) immunoaffinity columns to
DON- and ZEN-conjugated forms and metabolites. Food Addit. Contam. Part A Chem. Anal. Control Expo.
Risk Assess. 2011, 28, 1687–1693. [CrossRef] [PubMed]
38. Brezina, U.; Valenta, H.; Rempe, I.; Kersten, S.; Humpf, H.U.; Dänicke, S. Development of a liquid
chromatography tandem mass spectrometry method for the simultaneous determination of zearalenone,
deoxynivalenol and their metabolites in pig serum. Mycotoxin Res. 2014, 30, 171–186. [CrossRef] [PubMed]
39. Zhu, R.; Zhao, Z.; Wang, J.; Bing, B.; Wu, A.; Yan, L.; Song, S. A simple sample pretreatment method for
multi-mycotoxin determination in eggs by liquid chromatography tandem mass spectrometry. J. Chromatogr. A
2015, 1417, 1–7. [CrossRef] [PubMed]
40. Breidbach, A. A Greener, Quick and Comprehensive Extraction Approach for LC-MS of Multiple Mycotoxins.
Toxins 2017, 9, 91. [CrossRef] [PubMed]
41. Luongo, D.; De, L.R.; Russo, R.; Severino, L. Effects of four Fusarium toxins (fumonisin B(1), alpha-zearalenol,
nivalenol and deoxynivalenol) on porcine whole-blood cellular proliferation. Toxicon 2008, 52, 156–162.
[CrossRef] [PubMed]
42. Winkler, J.; Kersten, S.; Meyer, U.; Engelhardt, U.; Dänicke, S. Residues of zearalenone (ZEN), deoxynivalenol
(DON) and their metabolites in plasma of dairy cows fed Fusarium contaminated maize and their relationships
to performance parameters. Food Chem. Toxicol. 2014, 65, 196–204. [CrossRef] [PubMed]
43. Warth, B.; Sulyok, M.; Fruhmann, P.; Mikula, H.; Berthiller, F.; Schuhmacher, R.; Hametner, C.; Abia, W.A.;
Adam, G.; Fröhlich, J. Development and validation of a rapid multi-biomarker liquid chromatography/tandem
mass spectrometry method to assess human exposure to mycotoxins. Rapid Commun. Mass Spectrom. Rcm
2012, 26, 1533–1540. [CrossRef] [PubMed]
Toxins 2018, 10, 129 14 of 14
44. Jodlbauer, J.; Zöllner, P.; Lindner, W. Determination of zeranol, taleranol, zearalenone, α- and β-zearalenol in
urine and tissue by high-performance liquid chromatography-tandem mass spectrometry. Chromatographia
2000, 51, 681–687. [CrossRef]
45. Beltrán, E.; Ibáñez, M.; Portolés, T.; Ripollés, C.; Sancho, J.V.; Yusà, V.; Marín, S.; Hernández, F. Development of
sensitive and rapid analytical methodology for food analysis of 18 mycotoxins included in a total diet study.
Anal. Chim. Acta 2013, 783, 39–48. [CrossRef] [PubMed]
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
